• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

BRAF 激活的长链非编码 RNA 通过调节促甲状腺激素受体调节甲状腺癌细胞的增殖。

BRAF-Activated Long Noncoding RNA Modulates Papillary Thyroid Carcinoma Cell Proliferation through Regulating Thyroid Stimulating Hormone Receptor.

机构信息

Department of Surgery, Yantai Yuhuangding Hospital, Affiliated with Medical College of Qingdao University, Yantai, China.

出版信息

Cancer Res Treat. 2016 Apr;48(2):698-707. doi: 10.4143/crt.2015.118. Epub 2015 Aug 12.

DOI:10.4143/crt.2015.118
PMID:26323637
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4843736/
Abstract

PURPOSE

The importance of long noncoding RNAs (lncRNAs) in tumorigenesis has recently been demonstrated. However, the role of lncRNAs in development of thyroid cancer remains largely unknown.

MATERIALS AND METHODS

Using quantitative reverse transcription polymerase chain reaction, expression of three lncRNAs, including BRAF-activated long noncoding RNA (BANCR), papillary thyroid cancer susceptibility candidate 3 (PTCSC3), and noncoding RNA associated with mitogen-activated protein kinase pathway and growth arrest (NAMA), was investigated in the current study.

RESULTS

Of the three lncRNAs (BANCR, PTCSC3, and NAMA), expression of BANCR was significantly up-regulated while PTCSC3 and NAMA were significantly down-regulated in papillary thyroid carcinoma (PTC) compared to that in normal tissue. BANCR-knockdown in a PTC-derived cell line (IHH-4) resulted in significant suppression of thyroid stimulating hormone receptor (TSHR). BANCR-knockdown also led to inhibition of cell growth and cell cycle arrest at G0/G1 phase through down-regulation of cyclin D1. In addition, BANCR was enriched by polycomb enhancer of zeste homolog 2 (EZH2), and silencing BANCR led to decreased chromatin recruitment of EZH2, which resulted significantly reduced expression of TSHR.

CONCLUSION

These findings indicate that BANCR may contribute to the tumorigenesis of PTC through regulation of cyclin D1 and TSHR.

摘要

目的

长链非编码 RNA(lncRNA)在肿瘤发生中的重要性最近得到了证实。然而,lncRNA 在甲状腺癌发展中的作用在很大程度上仍然未知。

材料与方法

本研究采用定量逆转录聚合酶链反应,检测了三种 lncRNA 的表达,包括 BRAF 激活的长非编码 RNA(BANCR)、甲状腺乳头状癌易感候选基因 3(PTCSC3)和与丝裂原活化蛋白激酶途径和生长阻滞相关的非编码 RNA(NAMA)。

结果

在甲状腺乳头状癌(PTC)与正常组织相比,BANCR 的表达显著上调,而 PTCSC3 和 NAMA 的表达显著下调。在 PTC 来源的细胞系(IHH-4)中敲低 BANCR 可显著抑制促甲状腺激素受体(TSHR)。BANCR 敲低还通过下调细胞周期蛋白 D1 导致细胞生长抑制和 G0/G1 期细胞周期停滞。此外,BANCR 被 polycomb 增强子同源物 2(EZH2)富集,沉默 BANCR 导致 EZH2 染色质募集减少,从而显著降低 TSHR 的表达。

结论

这些发现表明,BANCR 可能通过调节细胞周期蛋白 D1 和 TSHR 促进 PTC 的肿瘤发生。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ee40/4843736/9e69eadfd3d9/crt-2015-118f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ee40/4843736/55cbaa6fb39c/crt-2015-118f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ee40/4843736/04d425b0c953/crt-2015-118f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ee40/4843736/f524108e5391/crt-2015-118f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ee40/4843736/1e601afd9bd0/crt-2015-118f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ee40/4843736/510395a8fa73/crt-2015-118f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ee40/4843736/9e69eadfd3d9/crt-2015-118f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ee40/4843736/55cbaa6fb39c/crt-2015-118f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ee40/4843736/04d425b0c953/crt-2015-118f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ee40/4843736/f524108e5391/crt-2015-118f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ee40/4843736/1e601afd9bd0/crt-2015-118f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ee40/4843736/510395a8fa73/crt-2015-118f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ee40/4843736/9e69eadfd3d9/crt-2015-118f6.jpg

相似文献

1
BRAF-Activated Long Noncoding RNA Modulates Papillary Thyroid Carcinoma Cell Proliferation through Regulating Thyroid Stimulating Hormone Receptor.BRAF 激活的长链非编码 RNA 通过调节促甲状腺激素受体调节甲状腺癌细胞的增殖。
Cancer Res Treat. 2016 Apr;48(2):698-707. doi: 10.4143/crt.2015.118. Epub 2015 Aug 12.
2
BRAF-activated LncRNA functions as a tumor suppressor in papillary thyroid cancer.BRAF激活的长链非编码RNA在甲状腺乳头状癌中发挥肿瘤抑制作用。
Oncotarget. 2017 Jan 3;8(1):238-247. doi: 10.18632/oncotarget.10825.
3
Long noncoding RNA PVT1 modulates thyroid cancer cell proliferation by recruiting EZH2 and regulating thyroid-stimulating hormone receptor (TSHR).长链非编码RNA PVT1通过招募EZH2并调节促甲状腺激素受体(TSHR)来调控甲状腺癌细胞的增殖。
Tumour Biol. 2016 Mar;37(3):3105-13. doi: 10.1007/s13277-015-4149-9. Epub 2015 Oct 1.
4
Expression of BANCR promotes papillary thyroid cancer by targeting thyroid stimulating hormone receptor.BANCR的表达通过靶向促甲状腺激素受体促进甲状腺乳头状癌。
Oncol Lett. 2018 Aug;16(2):2009-2015. doi: 10.3892/ol.2018.8810. Epub 2018 May 25.
5
Long non-coding RNA BANCR regulates cancer stem cell markers in papillary thyroid cancer via the RAF/MEK/ERK signaling pathway.长链非编码 RNA BANCR 通过 RAF/MEK/ERK 信号通路调节甲状腺乳头状癌中的癌症干细胞标志物。
Oncol Rep. 2018 Aug;40(2):859-866. doi: 10.3892/or.2018.6502. Epub 2018 Jun 18.
6
Identification of Specific Long Non-Coding RNA Expression: Profile and Analysis of Association with Clinicopathologic Characteristics and BRAF Mutation in Papillary Thyroid Cancer.乳头状甲状腺癌中特异性长链非编码RNA表达的鉴定:表达谱及与临床病理特征和BRAF突变的相关性分析
Thyroid. 2016 Dec;26(12):1719-1732. doi: 10.1089/thy.2016.0024. Epub 2016 Oct 31.
7
Identification of a novel noncoding RNA gene, NAMA, that is downregulated in papillary thyroid carcinoma with BRAF mutation and associated with growth arrest.一种新型非编码RNA基因NAMA的鉴定,该基因在伴有BRAF突变的甲状腺乳头状癌中表达下调,并与生长停滞相关。
Int J Cancer. 2007 Aug 15;121(4):767-75. doi: 10.1002/ijc.22701.
8
Elevated BANCR expression levels have different effects on papillary thyroid carcinoma progression depending on the presence of the BRAFV600E mutation.BANCR 表达水平的升高对伴有 BRAFV600E 突变的甲状腺乳头状癌的进展有不同的影响。
Eur J Surg Oncol. 2020 Oct;46(10 Pt A):1835-1842. doi: 10.1016/j.ejso.2020.05.027. Epub 2020 Jun 18.
9
[Effects of serine/threonine-protein kinase B-Raf-activated long-chain non-coding RNA on apoptosis and autophagy in thyroid carcinoma cells].丝氨酸/苏氨酸蛋白激酶B-Raf激活的长链非编码RNA对甲状腺癌细胞凋亡和自噬的影响
Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2018 Jul 28;43(7):747-753. doi: 10.11817/j.issn.1672-7347.2018.07.008.
10
Downregulation of long noncoding RNA H19 contributes to the proliferation and migration of papillary thyroid carcinoma.长链非编码RNA H19的下调促进甲状腺乳头状癌的增殖和迁移。
Gene. 2018 Mar 10;646:98-105. doi: 10.1016/j.gene.2017.12.051. Epub 2017 Dec 26.

引用本文的文献

1
Effect of long-stranded non-coding RNA-BANCR on the progression of thyroid papillary carcinoma and its mechanism.长链非编码RNA-BANCR对甲状腺乳头状癌进展的影响及其机制
Discov Oncol. 2025 Feb 10;16(1):147. doi: 10.1007/s12672-025-01755-5.
2
The role of genetic and epigenetic modifications as potential biomarkers in the diagnosis and prognosis of thyroid cancer.基因和表观遗传修饰作为甲状腺癌诊断和预后潜在生物标志物的作用。
Front Oncol. 2024 Nov 4;14:1474267. doi: 10.3389/fonc.2024.1474267. eCollection 2024.
3
LncRNA PFAR facilitates the proliferation and migration of papillary thyroid carcinoma by competitively binding to miR-15a.

本文引用的文献

1
TSHR intronic polymorphisms (rs179247 and rs12885526) and their role in the susceptibility of the Brazilian population to Graves' disease and Graves' ophthalmopathy.促甲状腺激素受体基因内含子多态性(rs179247和rs12885526)及其在巴西人群患格雷夫斯病和格雷夫斯眼病易感性中的作用。
J Endocrinol Invest. 2015 May;38(5):555-61. doi: 10.1007/s40618-014-0228-9. Epub 2014 Dec 28.
2
The association between histone 3 lysine 27 trimethylation (H3K27me3) and prostate cancer: relationship with clinicopathological parameters.组蛋白3赖氨酸27三甲基化(H3K27me3)与前列腺癌的关联:与临床病理参数的关系
BMC Cancer. 2014 Dec 23;14:994. doi: 10.1186/1471-2407-14-994.
3
长链非编码 RNA PFAR 通过与 miR-15a 竞争结合促进甲状腺乳头状癌的增殖和迁移。
Naunyn Schmiedebergs Arch Pharmacol. 2024 May;397(5):3037-3048. doi: 10.1007/s00210-023-02779-w. Epub 2023 Oct 24.
4
A review on the biological roles of LncRNA PTCSC3 in cancerous and non-cancerous disorders.长链非编码RNA PTCSC3在癌症及非癌症疾病中的生物学作用综述
Cancer Cell Int. 2023 Aug 29;23(1):184. doi: 10.1186/s12935-023-03037-y.
5
YTHDC2 Retards Cell Proliferation and Triggers Apoptosis in Papillary Thyroid Cancer by Regulating CYLD-Mediated Inactivation of Akt Signaling.YTHDC2 通过调控 CYLD 介导的 Akt 信号失活抑制甲状腺乳头状癌细胞增殖并诱导其凋亡。
Appl Biochem Biotechnol. 2024 Jan;196(1):588-603. doi: 10.1007/s12010-023-04540-8. Epub 2023 May 10.
6
Overexpression of ST7-AS1 Enhances Apoptosis and Inhibits Proliferation of Papillary Thyroid Carcinoma Cells Via microRNA-181b-5p-Dependent Inhibition Tripartite Motif Containing 3.ST7-AS1的过表达通过微小RNA-181b-5p依赖性抑制含三联体基序蛋白3增强甲状腺乳头状癌细胞的凋亡并抑制其增殖。
Mol Biotechnol. 2023 Mar;65(3):477-490. doi: 10.1007/s12033-022-00536-7. Epub 2022 Aug 27.
7
Knockdown of KRAB domain-associated protein 1 suppresses the proliferation, migration and invasion of thyroid cancer cells by regulating P68/DEAD box protein 5.敲低 KRAB 结构域相关蛋白 1 通过调控 P68/DEAD 盒蛋白 5 抑制甲状腺癌细胞的增殖、迁移和侵袭。
Bioengineered. 2022 May;13(5):11945-11957. doi: 10.1080/21655979.2022.2067289.
8
LINC01087 Promotes the Proliferation, Migration, and Invasion of Thyroid Cancer Cells by Upregulating PPM1E.LINC01087通过上调PPM1E促进甲状腺癌细胞的增殖、迁移和侵袭。
J Oncol. 2022 Mar 25;2022:7787378. doi: 10.1155/2022/7787378. eCollection 2022.
9
Epigenetic modification and BRAF gene mutation in thyroid carcinoma.甲状腺癌中的表观遗传修饰与BRAF基因突变
Cancer Cell Int. 2021 Dec 19;21(1):687. doi: 10.1186/s12935-021-02405-w.
10
LncRNA-MIAT promotes thyroid cancer progression and function as ceRNA to target EZH2 by sponging miR-150-5p.长链非编码 RNA-MIAT 通过海绵吸附 miR-150-5p 促进甲状腺癌的进展和功能作为 ceRNA 靶向 EZH2。
Cell Death Dis. 2021 Nov 22;12(12):1097. doi: 10.1038/s41419-021-04386-0.
Genetic predisposition to papillary thyroid carcinoma: involvement of FOXE1, TSHR, and a novel lincRNA gene, PTCSC2.
甲状腺乳头状癌的遗传易感性:FOXE1、TSHR及一种新型长链非编码RNA基因PTCSC2的作用
J Clin Endocrinol Metab. 2015 Jan;100(1):E164-72. doi: 10.1210/jc.2014-2147.
4
BRAF-activated long non-coding RNA contributes to cell proliferation and activates autophagy in papillary thyroid carcinoma.BRAF激活的长链非编码RNA促进甲状腺乳头状癌的细胞增殖并激活自噬。
Oncol Lett. 2014 Nov;8(5):1947-1952. doi: 10.3892/ol.2014.2487. Epub 2014 Aug 28.
5
Epigenetic silencing of TSHR gene in thyroid cancer patients in relation to their BRAF V600E mutation status.甲状腺癌患者中TSHR基因的表观遗传沉默与其BRAF V600E突变状态的关系。
Endocrine. 2014 Nov;47(2):449-55. doi: 10.1007/s12020-014-0319-6. Epub 2014 Jun 14.
6
Controversial constitutive TSHR activity: patients, physiology, and in vitro characterization.促甲状腺激素受体(TSHR)组成性激活的争议:患者、生理学和体外特征。
Horm Metab Res. 2014 Jun;46(7):453-61. doi: 10.1055/s-0034-1375651. Epub 2014 May 20.
7
Current thyroid cancer trends in the United States.美国当前的甲状腺癌趋势。
JAMA Otolaryngol Head Neck Surg. 2014 Apr;140(4):317-22. doi: 10.1001/jamaoto.2014.1.
8
A long non-coding RNA, PTCSC3, as a tumor suppressor and a target of miRNAs in thyroid cancer cells.一种长链非编码RNA,PTCSC3,作为甲状腺癌细胞中的肿瘤抑制因子和微小RNA的靶标。
Exp Ther Med. 2013 Apr;5(4):1143-1146. doi: 10.3892/etm.2013.933. Epub 2013 Jan 30.
9
Long noncoding RNAs: past, present, and future.长非编码 RNA:过去、现在和未来。
Genetics. 2013 Mar;193(3):651-69. doi: 10.1534/genetics.112.146704.
10
Down-regulation of the miR-25 and miR-30d contributes to the development of anaplastic thyroid carcinoma targeting the polycomb protein EZH2.miR-25 和 miR-30d 的下调导致多梳蛋白 EZH2 靶向的甲状腺未分化癌的发生。
J Clin Endocrinol Metab. 2012 May;97(5):E710-8. doi: 10.1210/jc.2011-3068. Epub 2012 Mar 7.